Company intelligence / Profile preview

Empatica

Cambridge/Boston, Massachusetts, United Statesempatica.com ↗

Ownership: Private
Development stage: Commercial

Overview

Empatica’s wearables and digital health platform are FDA-cleared for seizure detection in epilepsy patients and continuous physiological data collection. The company’s technology has been validated in thousands of academic studies and used by major pharmaceutical companies to monitor treatment effects and develop novel digital endpoints. Its solutions are deployed globally across clinical research, decentralized trials, public health initiatives, and real-world patient care.

Therapeutic areas: OtherNeurologyInfectious Diseases
Modalities: DeviceNon-pharmacological therapy (digital biomarkers/monitoring)Software platform (AI-enabled analytics)
Industry: Physiological Monitoring

Partnerships

AllucentBARDA/U.S. Biomedical Advanced Research & Development AuthorityTakedaChugaiAbbVie

Beyond the preview

Go deeper on Empatica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Empatica.

Explore the full profile